Biopharmaceutics plays a pivotal role in the pharmaceutical industry, especially concerning generic drugs. Unlike traditional pharmaceuticals, generic drugs are bioequivalent alternatives to their brand-name counterparts, delivering the same therapeutic effects and safety profiles. The study of biopharmaceutics focuses on understanding the intricate interplay between the drug formulation, its absorption, distribution, metabolism, and excretion within the human body.
In the realm of generic drugs, biopharmaceutics becomes a critical factor in ensuring that the generic version mirrors the performance of the original drug. This involves meticulous evaluation of factors such as dissolution rates, bioavailability, and pharmacokinetics. Through advanced techniques and research methodologies, biopharmaceutics contributes to the development of high-quality generic drugs, promoting accessibility and affordability in healthcare.
Furthermore, biopharmaceutics aids in optimizing drug delivery systems, enhancing the efficiency of drug absorption, and minimizing potential side effects. As the pharmaceutical landscape evolves, the synergy between biopharmaceutics and generic drugs continues to drive advancements, fostering innovation and expanding treatment options for a global patient population.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia